Quarterly ResultAug 5, 2026, 04:48 PM
BillionToOne Q2 Revenue $109.4M, Net Income $8.05M
AI Summary
BillionToOne, Inc. reported strong financial results for the second quarter and first half of 2026. For Q2 2026, revenue increased to $109.4 million from $66.6 million in Q2 2025, and the company achieved a net income of $8.05 million, a significant improvement from a net loss of $0.25 million in the prior year. The company also saw substantial growth in its prenatal and oncology segments, and entered into new agreements with payors that contributed to revenue.
Key Highlights
- Q2 2026 revenue reached $109.4 million, a significant increase from $66.6 million in Q2 2025.
- Q2 2026 net income was $8.05 million, compared to a net loss of $0.25 million in Q2 2025.
- Diluted EPS for Q2 2026 was $0.15, up from $(0.02) in the prior year period.
- Six months ended June 30, 2026 revenue was $217.8 million, up from $125.5 million in 2025.
- Six months ended June 30, 2026 net income was $26.02 million, compared to a net loss of $4.23 million in 2025.
- Prenatal revenue for Q2 2026 grew to $94.2 million from $60.8 million in Q2 2025.
- Oncology revenue for Q2 2026 increased to $13.7 million from $4.9 million in Q2 2025.
- Cash and cash equivalents stood at $548.6 million as of June 30, 2026.
Price Impact
More from BLLN